Latamoxef (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Latamoxef" in Italian language version.

refsWebsite

Global rank Italian rank

12nih.gov

4^th place

9^th place

nih.gov

ncbi.nlm.nih.gov

UB. Schaad, GH. McCracken; CA. Loock; ML. Thomas, Pharmacokinetics and bacteriological efficacy of moxalactam (LY127935), netilmicin, and ampicillin in experimental gram-negative enteric bacillary meningitis., in Antimicrob Agents Chemother, vol. 17, n. 3, marzo 1980, pp. 406-11, PMID 6448576.
R. Wise, S. Baker; N. Wright; R. Livingston, The pharmacokinetics of LY127935, a broad spectrum oxa-beta-lactam., in J Antimicrob Chemother, vol. 6, n. 3, maggio 1980, pp. 319-22, PMID 6447137.
JN. Parsons, JM. Romano; ME. Levison, Pharmacology of a new 1-oxa-beta-lactam (LY127935) in normal volunteers., in Antimicrob Agents Chemother, vol. 17, n. 2, febbraio 1980, pp. 226-8, PMID 6446259.
SE. Wilson, Cephalosporin therapy in intra-abdominal infection: comparative studies of cefotetan, latamoxef and cefoxitin., in Chemioterapia, vol. 7, n. 4, agosto 1988, pp. 213-7, PMID 3180298.
SE. Wilson, JA. Boswick; RJ. Duma; RM. Echols; JG. Jemsek; R. Lerner; RT. Lewis; AZ. Najem; RA. Press; MS. Rittenbury, Cephalosporin therapy in intraabdominal infections. A multicenter randomized, comparative study of cefotetan, moxalactam, and cefoxitin., in Am J Surg, vol. 155, 5A, maggio 1988, pp. 61-6, PMID 3287971.
TA. Stellato, LH. Danziger; T. Hau; MW. Gauderer; JL. Ferron; N. Gordon, Moxalactam vs tobramycin-clindamycin. A randomized trial in secondary peritonitis., in Arch Surg, vol. 123, n. 6, giugno 1988, pp. 714-7, PMID 3285809.
BJ. Fitzpatrick, HC. Standiford, A comparative evaluation of moxalactam: antimicrobial activity, pharmacokinetics, adverse reactions, and clinical efficacy., in Pharmacotherapy, vol. 2, n. 4, pp. 197-212, PMID 6221237.
WE. Thomas, MJ. Cooper; A. Holt; D. Reeves, Latamoxef: single agent prophylaxis in colorectal surgery., in J Antimicrob Chemother, vol. 16, n. 1, luglio 1985, pp. 121-8, PMID 4044462.
AA. Carmine, RN. Brogden; RC. Heel; JA. Romankiewicz; TM. Speight; GS. Avery, Moxalactam (latamoxef). A review of its antibacterial activity, pharmacokinetic properties and therapeutic use., in Drugs, vol. 26, n. 4, ottobre 1983, pp. 279-333, PMID 6354685.
GR. Peters, CM. Metzler, The effects of cefmetazole and latamoxef on platelet function in healthy human volunteers., in J Antimicrob Chemother, 23 Suppl D, aprile 1989, pp. 119-23, PMID 2722718.
MR. Weitekamp, RC. Aber, Prolonged bleeding times and bleeding diathesis associated with moxalactam administration., in JAMA, vol. 249, n. 1, gennaio 1983, pp. 69-71, PMID 6217353.
RB. Brown, J. Klar; S. Lemeshow; D. Teres; H. Pastides; M. Sands, Enhanced bleeding with cefoxitin or moxalactam. Statistical analysis within a defined population of 1493 patients., in Arch Intern Med, vol. 146, n. 11, novembre 1986, pp. 2159-64, PMID 3778044.